The slip
PARKINSON RECEIPTno. 4995
21 Oct 2026, 05:40 UTCdopamine neurons, braak
predictionPGF in dopamine neurons tracks Braak Lewy-body stage
registered08d96daaa1e33f40
discovery-0.20 p=0.607 n=9
replication-0.87 p=0.0021 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.20, p 0.607)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTd68dfe970c5d3a630cb28984…
follows 75535a9ea4e2…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4995: PGF in dopamine neurons, braak
- power
- full sample -0.54 (p 0.019, n 18), 95% CI -0.81 to -0.10. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.56 (p 0.016, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.66 (p 0.0030, n 18). not the mix.
- skeptic
- leave-one-out range -0.66 to -0.48, sign flips 0; without severely affected donors -0.54 (p 0.019, n 18). robust.
- cell type
- strongest in astrocytes: -0.61 (p 0.0069, n 18) vs -0.54 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PGF in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up PGF · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.07 p 0.790 (needs p < 3.9e-4)